COVID-19: Moderna vaccine shows 94.1 per cent efficacy in trial, according to study
The study enrolled 30,420 adult participants at 99 sites in the US, including over 600 participants enrolled at the Brigham.
Full Article
COVID-19: Moderna vaccine shows 94.1 per cent efficacy in trial, according to study
DNA
0 shares
1 views
You might like
Related news coverage
Moderna COVID-19 Vaccine Trial Shows 94.1 Percent Efficacy
Eurasia Review
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which..
America’s Deadliest Year, In Numbers – OpEd
Eurasia Review
-
Moderna vaccine shows 94.1% efficacy in trial: Study
IndiaTimes
-
COVID-19 dominates 2020 for biotech sector … and everyone else
Proactive Investors
Advertisement
More coverage
Starpharma’s COVID-19 nasal spray to be ready for market next quarter
Starpharma Holdings Limited (ASX:SPL) (OTCMKTS:SPHRF) has made strong commercial and regulatory progress with its VIRALEZE™..
Proactive Investors
Moderna to make up to 125 million COVID-19 vaccine doses available globally
US-based drugmaker Moderna has said that it expects to have between 100 million and 125 million doses of its experimental Covid-19..
Mid-Day